Clinical Trial Update: Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates escalating single-dose safety, tolerability, and pharmacokinetics of SQ109 in healthy volunteers. The goal is to characterize its e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• SQ109 (SQ109)

Snippet

Sponsor: Sequella, Inc. | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED